As at Jun 3, 2026, the XTNT stock has a PE ratio of 23.01. This is based on the current EPS of $0.02 and the stock price of $0.46 per share.
The mean historical PE ratio of Xtant Medical Holdings over the last ten years is 40.89. The current 23.01 PE ratio is 44% below the historical average. Over the past ten years, XTNT's PE ratio was at its highest in the Dec 2023 quarter at 113, with a price of $1.13 and an EPS of $0.01. The Sep 2016 quarter recorded the bottom point at 5.06, with a price of $13.56 and an EPS of $2.68.
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 19.5 | N/A | $0.78 | $0.04 |
| 2024 | N/A | N/A | $0.44 | -$0.12 |
| 2023 | 113 | N/A | $1.13 | $0.01 |
| 2022 | N/A | N/A | $0.66 | -$0.09 |
| 2021 | N/A | N/A | $0.56 | -$0.06 |
| 2020 | N/A | N/A | $1.2 | -$0.25 |
| 2019 | N/A | N/A | $1.6 | -$0.63 |
| 2018 | N/A | N/A | $1.61 | -$5.97 |
| 2017 | N/A | N/A | $6.87 | -$34.76 |
| 2016 | N/A | N/A | $6.6 | -$18.46 |
| 2015 | N/A | N/A | $33.6 | -$2.88 |
| 2014 | N/A | N/A | $36.36 | -$21.1 |
| 2013 | N/A | N/A | $60 | -$33.6 |
| 2012 | N/A | N/A | $150 | -$21.6 |
| 2011 | N/A | N/A | $343.2 | -$9.6 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 27.9 | 43.08% | $0.56 | $0.02 |
| Dec 2025 | 19.5 | -40% | $0.78 | $0.04 |
| Sep 2025 | 32.5 | N/A | $0.65 | $0.02 |
| Jun 2025 | N/A | N/A | $0.74 | -$0.03 |
| Mar 2025 | N/A | N/A | $0.47 | -$0.09 |
| Dec 2024 | N/A | N/A | $0.44 | -$0.12 |
| Sep 2024 | N/A | N/A | $0.68 | -$0.13 |
| Jun 2024 | N/A | N/A | $0.63 | -$0.02 |
| Mar 2024 | N/A | N/A | $1.17 | -$0.01 |
| Dec 2023 | 113 | 2.73% | $1.13 | $0.01 |
| Sep 2023 | 110 | N/A | $1.1 | $0.01 |
| Jun 2023 | N/A | N/A | $0.93 | -$0.09 |
| Mar 2023 | N/A | N/A | $0.64 | -$0.09 |
| Dec 2022 | N/A | N/A | $0.66 | -$0.09 |
| Sep 2022 | N/A | N/A | $0.72 | -$0.11 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of XTNT is below the 3, 5 and 10-year averages.
Xtant Medical Holdings's P/E of 23.01 is below the Healthcare sector and the industry average. But compared to its Healthcare sector average of 23.02, Xtant Medical Holdings's P/E is only 0% lower.
Compared to its peer stocks SYK and STE, XTNT's PE ratio stands lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| XTNT Xtant Medical Holdings Inc | 23.08 | $64.73M |
| STE STERIS plc | 26.63 | $20.71B |
| SYK Stryker Corp | 34.44 | $115.39B |
As of Jun 3, 2026, XTNT stock has a price to earnings ratio of 23.01.
The 3-year average PE ratio for XTNT stock is 60.58.
The 5-year average PE ratio for XTNT stock is 46.0.
Over the last ten years, the quarterly PE ratio reached a historic high of 113 in the Dec 2023 quarter.
XTNT's current price to earnings ratio is 44% below its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 3, 2026), Xtant Medical Holdings's stock price is $0.46. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.02. Therefore, Xtant Medical Holdings's P/E ratio for today is 23.01. PE RATIO(23.01) = STOCK PRICE($0.46) / TTM EPS($0.02)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.